With increasing information overload and packed work schedules, staying up-to-date on the newest oncologic advances is harder than ever. But take heart! The QuadShot is freshly brewed in your inbox four mornings each week so you can quickly down and digest the day's most pertinent cancer news.
This NCDB study found that between ages 69 and 70, there was a significant drop in the utilization of adjuvant RT for breast cancer from ~90% for those between 50 and 69 to ~80% for those age 70. | Talcott, Int J Radiat Oncol Biol Phys 2023
Comments
Post a Comment